MaxCyte, Inc.
MXCT
$1.41
$0.0151.08%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -21.32% | -14.48% | -6.44% | 19.85% | 11.69% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -21.32% | -14.48% | -6.44% | 19.85% | 11.69% |
Cost of Revenue | 37.44% | 39.83% | 49.73% | 35.56% | -0.64% |
Gross Profit | -29.00% | -21.66% | -13.73% | 17.63% | 13.53% |
SG&A Expenses | -3.72% | -2.78% | -1.21% | 9.80% | 16.04% |
Depreciation & Amortization | -0.38% | -0.12% | 3.96% | 10.28% | 20.89% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -2.73% | -2.80% | 0.27% | 8.23% | 12.69% |
Operating Income | -15.52% | -8.06% | -6.00% | 1.20% | -13.70% |
Income Before Tax | -26.37% | -14.28% | -8.26% | 4.59% | -8.56% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -26.37% | -14.28% | -8.26% | 4.59% | -8.56% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -26.37% | -14.28% | -8.26% | 4.59% | -8.56% |
EBIT | -15.52% | -8.06% | -6.00% | 1.20% | -13.70% |
EBITDA | -17.28% | -8.92% | -6.24% | 2.17% | -13.09% |
EPS Basic | -24.21% | -12.34% | -6.53% | 5.97% | -7.14% |
Normalized Basic EPS | -24.23% | -12.37% | -6.58% | 5.94% | -7.20% |
EPS Diluted | -24.21% | -12.34% | -6.53% | 5.97% | -7.14% |
Normalized Diluted EPS | -24.23% | -12.37% | -6.58% | 5.94% | -7.20% |
Average Basic Shares Outstanding | 1.71% | 1.68% | 1.53% | 1.47% | 1.48% |
Average Diluted Shares Outstanding | 1.71% | 1.68% | 1.53% | 1.47% | 1.48% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |